title: Osteonecrosis of the jaw.
authors.forename: Ebru
authors.initials: E
authors.lastname: Sari
authors.forename: Nilufer
authors.initials: N
authors.lastname: Bulut
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006620:Hip Fractures / Q000517:prevention & control; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D007571:Jaw Diseases / Q000139:chemically induced*; D010020:Osteonecrosis / Q000139:chemically induced*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D000077268:Pamidronate; D013997:Time Factors; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate